CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Jianmin Pharmaceutical Group Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Jianmin Pharmaceutical Group Co Ltd
No.484 Yingwu Avenue, Hanyang District
Phone: +86 2784523350p:+86 2784523350 WUHAN, HUB  430052  China Ticker: 600976600976
Business Summary
JIANMIN PHARMACEUTICAL GROUP CO., LTD., formerly Wuhan Jianmin Pharmaceutical Groups Co. Ltd, is a China-based company, principally engaged in the research and development, manufacture, wholesale and retailing of pharmaceuticals. The Company operates its businesses through two segments, including Pharmaceutical Industry and Pharmaceutical Business. The Pharmaceutical Industry segment is engaged in the research and development and manufacture of pharmaceuticals. Its products are mainly applied in children, women and the elderly, among others. The Pharmaceutical Business segment is engaged in the wholesale and retailing of pharmaceuticals. Its products include traditional Chinese medicine, Western medicine, health products, medical equipment and chemical agents. It distributes its products mainly in domestic market.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
5912 Drug stores and proprietary stores
5122 Drugs, drug proprietaries, and druggists' sundries
8062 General medical and surgical hospitals

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board QinHe 62
President, Director JunWang 45
Chief Financial Officer ZhaoyangCheng 50 1/1/2019 1/1/2019
11 additional Officers and Directors records available in full report.

Business Names
Business Name
600976
Wuhan Jianmin Pharmaceutical Group Co.
Wuhan Jianmin Pharmaceutical Groups Co.

General Information
Number of Employees: 2,497 (As of 12/31/2023)
Outstanding Shares: 152,949,600 (As of 3/31/2024)
Shareholders: 11,318
Stock Exchange: SHA
Fax Number: +86 2784523350


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 24, 2024